B-MORE-Pilot: Breathing-Induced Myocardial Oxygenation Reserve

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre (Other)
Overall Status
Suspended
CT.gov ID
NCT03050346
Collaborator
University Hospital Heidelberg (Other), Groote Schuur Hospital (Other), King's College London (Other), University of Wisconsin, Madison (Other), Jewish General Hospital (Other)
160
6
66
26.7
0.4

Study Details

Study Description

Brief Summary

This is a clinical trial to test the clinical feasibility and safety of a novel CMR protocol, combined with a specific breathing maneuver to identify myocardial regions exposed to severe coronary artery stenosis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a clinical trial to test the clinical feasibility and safety of a novel CMR protocol. It aims to investigate a new Cardiovascular Magnetic Resonance (CMR) technique, called oxygenation-sensitive CMR (OS-CMR).

    OS-CMR is a T2*-sensitive CMR sequence based on the so-called blood-oxygen-level-dependent (BOLD) effect. Because de-oxygenated hemoglobin acts as an endogenous paramagnetic contrast agent, the signal intensity (SI) in OS-CMR images is linearly correlated with hemoglobin oxygenation in the tissue. An increase in deoxyhemoglobin results in an drop in SI in OS-CMR images, while an increase in tissue oxygenation results in an increase in SI.

    Therefore, OS-CMR has been found capable of assessing myocardial oxygenation and is being increasingly used to identify the vascular response of the coronary circulation to different stimuli.

    Very recently, OS-CMR was used to identify the coronary vascular response to specific breathing maneuvers. Specifically, a marked increase of myocardial oxygenation was observed during a long breath-hold following a 60s period of hyperventilation. The combination of these two maneuvers appear to induce consistent and detectable changes of myocardial oxygenation, based on CO2-mediated coronary vasoconstriction and vasodilation, while being well tolerated by participants.

    In this study, the investigators will use breathing maneuvers as coronary vasoactive stimuli to assess the myocardial oxygenation changes induced by such maneuvers with OS-CMR.

    The investigators aim to assess if the breathing-induced relative increase of myocardial oxygenation (Breathing-induced Myocardial Oxygenation REserve, B-MORE) in a coronary territory is clinically feasible to serve as a marker for the severity of coronary artery stenosis.

    Moreover, the investigators will assess the feasibility and safety of OS-CMR with breathing maneuvers in patients with suspected coronary artery disease in a multi-center setting.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    160 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Breathing-Induced Myocardial Oxygenation Reserve - Pilot Study (B-MORE-Pilot)
    Study Start Date :
    Jan 1, 2016
    Actual Primary Completion Date :
    Jun 1, 2019
    Anticipated Study Completion Date :
    Jul 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    CAD patients

    Consecutive patients scheduled for a coronary angiography on the basis of cardiac symptoms and a test positive for inducible coronary ischemia, who are affected by one-vessel or two-vessel CAD at the time of the OS-CMR with breathing maneuvers (HVBH).

    Healthy subjects

    Subjects without current or pre-existing cardiovascular and lung disease and absence of medication with cardiovascular effects.

    Outcome Measures

    Primary Outcome Measures

    1. Comparison of myocardial oxygenation signal intensity changes (OS-SI) changes between healthy and post-stenotic myocardium during OS-CMR with breathing-maneuvers in CAD patients. [OS-CMR with breathing maneuvers will last about 5-10 minutes]

      Myocardial oxygenation signal intensity changes (OS-SI) changes between healthy and post-stenotic myocardium during OS-CMR with breathing-maneuvers

    Secondary Outcome Measures

    1. Relationship between OS-SI changes during OS-CMR with breathing-maneuvers and Fractional Flow Reserve (FFR) measurements in CAD patients [OS-CMR with breathing maneuvers will last about 5-10 minutes]

      Myocardial oxygenation signal intensity changes (OS-SI) changes during OS-CMR with breathing-maneuvers and its relation to Fractional Flow Reserve (FFR) measurements

    2. Relationship between OS-SI changes during OS-CMR with breathing-maneuvers and Quantitative Coronary Angiography (QCA) measurements in CAD patients [OS-CMR with breathing maneuvers will last about 5-10 minutes]

      Myocardial oxygenation signal intensity changes (OS-SI) changes during OS-CMR with breathing-maneuvers and its relation to Quantitative Coronary Angiography (QCA) measurements

    3. Presence of side effects during OS-CMR with breathing maneuvers [OS-CMR with breathing maneuvers will last about 5-10 minutes]

      side effects experienced by the participants during breathing maneuvers

    4. Clinical feasibility of OS-CMR with breathing maneuvers [OS-CMR with breathing maneuvers will last about 5-10 minutes]

      Number of participants who voluntarily stopped the maneuver prior to completion and scan time of the image acquisition protocol.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age > 18 y

    • Informed consent as documented by signature (Appendix Informed Consent Form)

    • Indication for invasive coronary angiography based on symptoms and a test positive for inducible coronary ischemia

    • One-vessel or two-vessel CAD at coronary angiography (For healthy volunteers: absence of current or pre-existing cardiovascular and lung disease and absence of medication with cardiovascular effects)

    Exclusion Criteria:
    • General MRI contraindications (i.e pacemakers, defibrillating wires, implanted defibrillators, intracranial aneurysm clips, metallic foreign bodies in the eyes, knowledge or suspicion of pregnancy)

    • Acute Coronary Syndrome (ACS) or other acute cardiac injury within 4 weeks

    • Previous myocardial infarction, percutaneous coronary intervention or coronary artery bypass surgery

    • Hemodynamically unstable conditions

    • Significant or uncontrolled arrhythmias

    • Lack of ability to follow commands

    • Vasoactive medication (e.g. nitro or ß blockers) or nutrition with caffeine (coffee, tea, cocoa, chocolate, "energy drink") during the 12 h before the exam

    • Non-ischemic cardiomyopathy

    • Severe Pulmonary Disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Wisconsin Madison Wisconsin United States 53792
    2 Jewish General Hospital Montreal Quebec Canada 3755
    3 McGill University Health Centre Montreal Quebec Canada H4A 3J1
    4 University Hospital Heidelberg Heidelberg Germany 69120
    5 Groote Schuur Hospital Cape Town South Africa 7935
    6 King's College London London United Kingdom WC2R 2LS

    Sponsors and Collaborators

    • McGill University Health Centre/Research Institute of the McGill University Health Centre
    • University Hospital Heidelberg
    • Groote Schuur Hospital
    • King's College London
    • University of Wisconsin, Madison
    • Jewish General Hospital

    Investigators

    • Principal Investigator: Matthias Friedrich, MD, McGill University Health Centre/Research Institute of the McGill University Health Centre

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Matthias Friedrich, Chief, Cardiovascular Imaging, McGill University Health Centre, McGill University Health Centre/Research Institute of the McGill University Health Centre
    ClinicalTrials.gov Identifier:
    NCT03050346
    Other Study ID Numbers:
    • 15-398-MUHC
    First Posted:
    Feb 10, 2017
    Last Update Posted:
    Mar 10, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Matthias Friedrich, Chief, Cardiovascular Imaging, McGill University Health Centre, McGill University Health Centre/Research Institute of the McGill University Health Centre
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 10, 2021